213
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Toxicology of long‐term and high-dose administration of methylphenidate on the kidney tissue – a histopathology and molecular study

, , , , , , , , & ORCID Icon show all
Pages 611-619 | Received 18 Jun 2020, Accepted 31 Jul 2020, Published online: 03 Sep 2020

References

  • Abbasnezhad M, Jafari M, Asgari A, Hajihoseini R, Hajigholamali M, Salehi M, Salimian M. 2009. The study regarding effect of paraoxon on oxidative stress index in kidney tissue of rats. Mazand Univ Med Sci. 19:17–26.
  • Aebi H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126.
  • Andrzejewski ME, Spencer RC, Harris RL, Feit EC, Mckee BL, Berridge CW. 2014. The effects of clinically relevant doses of amphetamine and Methylphenidate on signal detection and DRL in rats. Neuropharmacology. 79:634–641.
  • Biederman J. 1998. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry. 59:4–16.
  • Biederman J, Spencer T, Wilens T. 2004. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 7(1):77–97.
  • Dela Peña I, Kim HJ, Sohn A, Kim B-N, Han DH, Ryu JH, Shin CY, Noh M, Cheong JH. 2014. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Funct. 10:17.
  • Ellman GI. 1959. Tissue sulphhydryl groups. Arch. Biochem. Biophys. 82:70–77.
  • Eslami AA, Jalilian F, Ataee M, Alavijeh MM, Mahboubi M, Afsar A, Aghaei A. 2014. Intention and willingness in understanding Ritalin misuse among Iranian medical college students: a cross-sectional study. Glob J Health Sci. 6(6):43–53.
  • Fischer WJ, Dietrich DR. 2000. Pathological and biochemical characterization of microcystin-induced hepatopancreas and kidney damage in carp (Cyprinus carpio). Toxicol Appl Pharmacol. 164(1):73–81.
  • Gomes KM, Inácio CG, Valvassori SS, Réus GZ, Boeck CR, Dal-Pizzol F, Quevedo J. 2009. Superoxide production after acute and chronic treatment with Methylphenidate in young and adult rats. Neurosci Lett. 465(1):95–98.
  • Gomes KM, Petronilho FC, Mantovani M, Garbelotto T, Boeck CR, Dal-Pizzol F, Quevedo J. 2008. Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res. 33(6):1024–1027.
  • Gonçalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP. 2010. Methamphetamine‐induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci. 31(2):315–326.
  • Kodama T, Kojima T, Honda Y, Hosokawa T, Tsutsui K-I, Watanabe M. 2017. Oral administration of Methylphenidate (ritalin) affects dopamine release differentially between the prefrontal cortex and striatum: a microdialysis study in the monkey. J Neurosci. 37(9):2387–2394.
  • Levine B, Caplan YH, Kauffman G. 1986. Fatality resulting from methylphenidate overdose. J Anal Toxicol. 10(5):209–210.
  • Liu T, Zhang L, Joo D, Sun S-C. 2017. NF-κB signaling in inflammation. Sig Transduct Target Ther. 2(1):1–9.
  • Loureiro-Vieira S, Costa VM, Duarte JA, Duarte-Araújo M, Gonçalves-Monteiro S, De Lourdes BM, Carvalho F, Capela JP. 2018. Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats. Biomed Pharmacother. 100:551–563.
  • Ma J, Wan J, Meng J, Banerjee S, Ramakrishnan S, Roy S. 2014. Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor. Cell Death Dis. 5:e1099.
  • Marklund S, Marklund G. 1974. Involvement of the superoxide anìon radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47:469–474.
  • Massello W, Carpenter D. 1999. A fatality due to the intranasal abuse of methylphenidate (ritalin®). J Forensic Sci. 44:220–221.
  • Morton WA, Stockton GG. 2000. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry. 2(5):159–164.
  • Motaghinejad M, Motevalian M, Shabab B. 2016. Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Neurosci Lett. 619:106–113.
  • Mott TF, Leach L. 2004. Is methylphenidate useful for treating adolescents with ADHD? Clin Inquiries. 53(8):659–663.
  • Nopparat C, Porter JE, Ebadi M, Govitrapong P. 2010. The mechanism for the neuroprotective effect of melatonin against methamphetamine‐induced autophagy. J Pineal Res. 49(4):382–389.
  • Paolo Busardò F, Kyriakou C, Cipolloni L, Zaami S, Frati P. 2016. From clinical application to cognitive enhancement: the example of Methylphenidate. Curr Neuropharmacol. 14(1):17–27.
  • Pouraman M, Kianifard D. 2019. Study of the effects of time dependent administration of methylphenidate on the histological structure of liver and kidney in adult male and female rats. Journal of Fasa University of Medical Sciences. 9:1248–1256.
  • Raoofi A, Aliaghaei A, Abdollahifar M-A, Boroujeni ME, Javadinia SS, Atabati H, Abouhamzeh B. 2020. Long-term administration of high-dose methylphenidate-induced cerebellar morphology and function damage in adult rats. J Chem Neuroanat. 103:101712.
  • Réus GZ, Scaini G, Jeremias GC, Furlanetto CB, Morais MO, Mello-Santos LM, Quevedo J, Streck EL. 2014. Brain apoptosis signaling pathways are regulated by methylphenidate treatment in young and adult rats. Brain Res. 1583:269–276.
  • Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ. 2012. Correction: Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. PloS One. 7(5). DOI:10.1371/annotation/c76da2c1-ccb8-4797-94c1-359d3ceceeda
  • Salviano LHMS, Linhares MI, de Lima KA, de Souza AG, Lima DB, Jorge ARC, da Costa MFB, Filho AJMC, Martins AMC, Monteiro HSA, et al. 2015. Study of the safety of methylphenidate: focus on nephrotoxicity aspects. Life Sci. 141:137–142.
  • Sameni HR, Seiri M, Safari M, Amjad MHT, Khanmohammadi N, Zarbakhsh S. 2019. Bone marrow stromal cells with the granulocyte colony-stimulating factor in the management of chemotherapy-induced ovarian failure in a rat model. Iranian J Med Sci. 44:135.
  • Scherer EB, Matté C, Ferreira AG, Gomes KM, Comim CM, Mattos C, Quevedo J, Streck EL, Wyse AT. 2009. Methylphenidate treatment increases Na+, K+-ATPase activity in the cerebrum of young and adult rats. J Neural Transm. 116(12):1681–1687.
  • Schmitz F, Da Silva Scherer EB, Da Cunha MJ, Da Cunha AA, Lima DD, Delwing D, Netto CA, De Souza Wyse AT. 2012. Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats. Mol Cell Biochem. 361(1–2):281–288.
  • Schmitz F, Da Silva Scherer EB, Machado FR, Da Cunha AA, Tagliari B, Netto CA, Wyse AT. 2012. Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab Brain Dis. 27(4):605–612.
  • Sriram K, O’Callaghan JP. 2007. Divergent roles for tumor necrosis factor-α in the brain. J Neuroimmune Pharmacol. 2(2):140–153.
  • Stecyk O, Loludice TA, Demeter S, Jacobs J. 1985. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med. 14(6):597–599.
  • Takasusuki T, Fujiwara T, Yamaguchi S, Fukushima T, Akagawa K, Hori Y. 2007. Enhancement of synaptic transmission and nociceptive behaviour in HPC‐1/syntaxin 1A knockout mice following peripheral nerve injury. Eur J Neurosci. 26(8):2179–2187.
  • Tremblay S, Pieper F, Sachs A, Joober R, Martinez-Trujillo J. 2019. The effects of methylphenidate (ritalin) on the neurophysiology of the monkey caudal prefrontal cortex. eNeuro. 6(1):1–17. DOI:10.1523/ENEURO.0371-18.2018
  • Volkow ND, Gatley SJ, Fowler JS, Wang G-J, Swanson J. 2000. Serotonin and the therapeutic effects of ritalin. Science. 288(5463):11.
  • Wender PH. 1998. Attention-deficit hyperactivity disorder in adults. Psychiatr Clin North Am. 21(4):761–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.